AORT Artivion, Inc. Common Stock
$28,89
Precio · Ago 18, 2026
Fundamentales a fecha de Ago 7, 2026
Rango 52S
$19–$48
33% of range
Calificación del Analista
BUY
14 analysts
Precio Objetivo
$42
+46% upside
P/E (TTM)
139.4
ROE
2.2%
Margen de Beneficio Neto
2.2%
Acerca de Artivion, Inc. Common Stock Descripción general de la empresa de Wikipedia
Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive.
Leer más
Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive.
## History
Artivion was founded as CryoLife in Sarasota, Florida in 1984 by Steven Anderson and Robert McNally. Anderson acted as the company’s president and CEO from its founding. The company later moved from Sarasota to the Atlanta metropolitan area. In January 2022 the company changed its name to Artivion, Inc.
In 2000, CryoLife began offering a surgical adhesive called BioGlue used for sealing surgical lacerations under high pressure, such as in arteries.
In February 2008, the FDA gave CryoLife approval for a new kind of heart valve, made from human tissues, which was the first to remove cells from the transplant tissue as opposed to only cleaning the tissue. In giving the approval, the FDA said the new valve, called the CryoValve SynerGraft Pulmonary Valve, had less of a chance of rejection than previous valves.
In 2010, CryoLife acquired the rights to manufacture and distribute PerClot, an absorbable hemostatic powder used in surgery.
In January 2016, the company acquired On-X Life Technologies and its principal product, a mechanical heart valve called the On-X aortic valve replacement, for $130 million.
In October 2017, Artivion acquired JOTEC GmbH, a German-based developer of medical devices for aortic and peripheral vascular diseases, for €225 million. In September 2020, the company acquired Ascyrus Medical.
In 2021, the company received FDA premarket application approval of its PerClot absorbable hemostatic system, which comprised PerClot granules and a delivery system for surgical use. Baxter International agreed to buy PerClot from Artivion in 2021. In 2023, after final FDA approval of the product, the purchase was completed.
Fuente: Wikipedia (Inglés), CC BY-SA 4.0 · Ver en Wikipedia ↗
AORT Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$28.89
Capitalización Bursátil
$1.44B
P/E (TTM)
139.4
BPA (TTM)
$0.21
Ingresos (TTM)
$441M
Rendimiento div.
—
ROE
2.2%
Deuda/Capital
0.5
Rango 52S
$19 – $48
AORT Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$441M
2016-12-31
→
2025-12-31
BPA
$0.21
2016-12-31
→
2025-12-31
Flujo de caja libre
$839.0K
2016-12-31
→
2025-12-31
Márgenes
2.2%
2016-12-31
→
2025-12-31
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
AORT
Mediana de Pares
P/E (TTM)
139.4
38.5
P/S (TTM) (P/V (TTM))
3.3
2.5
P/B (P/C)
3.2
4.8
EV / EBITDA
28.4
—
Price / FCF (Precio / FCF)
1720.8
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
AORT
Mediana de Pares
Gross Margin (Margen Bruto)
64.4%
58.7%
Operating Margin (Margen Operativo)
7.6%
—
Net Profit Margin (Margen de Beneficio Neto)
2.2%
-12.6%
ROA
1.2%
-11.8%
ROE
2.2%
-37.7%
ROIC
3.4%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
AORT
Mediana de Pares
Debt / Equity (Deuda / Patrimonio)
0.5
25.5
Current Ratio (Ratio corriente)
3.5
3.5
Quick Ratio (Ratio Rápido)
1.5
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
AORT
Mediana de Pares
Revenue YoY (Ingresos interanuales)
13.6%
—
Revenue CAGR 3Y (Ingresos CAGR 3A)
12.0%
—
Revenue CAGR 5Y (Ingresos CAGR 5A)
11.8%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
AORT
Mediana de Pares
Dividendos Rendimiento, ratio de pago, historial de dividendos, CAGR a 5 años
Rendimiento por Dividendo
—
Ratio de Pago
—
CAGR de Dividendos a 5 años
—
| Fecha ex-dividendo | Monto |
|---|---|
| 9 de diciembre de 2015 | $0,0300 |
| 9 de septiembre de 2015 | $0,0300 |
| 10 de junio de 2015 | $0,0300 |
| 11 de marzo de 2015 | $0,0300 |
| 10 de diciembre de 2014 | $0,0300 |
| 10 de septiembre de 2014 | $0,0300 |
| 11 de junio de 2014 | $0,0300 |
| 12 de marzo de 2014 | $0,0280 |
| 11 de diciembre de 2013 | $0,0280 |
| 11 de septiembre de 2013 | $0,0280 |
| 12 de junio de 2013 | $0,0280 |
| 12 de marzo de 2013 | $0,0250 |
| 12 de diciembre de 2012 | $0,0250 |
| 12 de septiembre de 2012 | $0,0250 |
AORT Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
14 analistas
- Compra fuerte 5 35,7%
- Compra 8 57,1%
- Mantener 1 7,1%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
8 analistas · 2026-08-18
Mediana
$42.00
← Por Debajo de Todos los Objetivos
$28.89
Mín
$38.00
Máx
$48.00
Objetivo mediano
$42.00
+45,4%
Objetivo medio
$42.15
+45,9%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-0.02%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 30 de junio de 2026 | $-0.28 | $0.01 | -0.29% |
| 31 de marzo de 2026 | $0.03 | $0.05 | -0.02% |
| 31 de diciembre de 2025 | $0.05 | $0.08 | -0.03% |
| 30 de septiembre de 2025 | $0.06 | $0.02 | 0.04% |
| 30 de junio de 2025 | $0.08 | $-0.00 | 0.08% |
| 31 de marzo de 2025 | $-0.01 | $-0.12 | 0.11% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| AORT | $2.25B | 217.2 | 13.6% | 2.2% | 2.2% | 64.4% |
| TNDM | $1.50B | -7.2 | 7.9% | -20.2% | -141.9% | 53.8% |
| CNMD | $1.27B | 26.9 | 5.2% | 3.4% | 4.6% | 54.6% |
| ATEC | $3.16B | -21.9 | 24.9% | -18.8% | -792.1% | 69.6% |
| ENOV | $1.52B | -1.3 | 6.7% | -52.7% | -58.5% | 59.8% |
| IART | — | -1.8 | 1.5% | -31.6% | -49.6% | — |
| KMTS | $1.21B | -8.5 | 59.0% | -138.4% | -62.1% | 51.4% |
| PRCT | $1.77B | -18.3 | 37.2% | -31.0% | -25.4% | 63.7% |
| IRMD | $1.24B | 55.6 | 14.4% | 26.8% | 23.8% | 76.8% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 18
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $441M | $389M | $354M | $314M | $299M | $253M | $276M | $263M | $190M | $180M | $146M | $145M | |
| Cost of Revenue | $157M | $140M | $125M | $111M | $101M | $85M | $93M | $90M | $61M | $61M | $55M | $53M | |
| Gross Profit | $284M | $249M | $229M | $203M | $198M | $168M | $183M | $173M | $129M | $119M | $91M | $91M | |
| R&D Expense | $31M | $28M | $29M | $39M | $36M | $24M | $23M | $23M | $19M | $13M | $10M | $9M | |
| SG&A Expense | $226M | $181M | $209M | $157M | $170M | $141M | $143M | $141M | $101M | $92M | $75M | $74M | |
| Operating Expenses | $257M | $210M | $238M | $196M | $205M | $165M | $166M | $164M | $121M | $105M | $85M | $82M | |
| Operating Income | $34M | $39M | $6M | $6M | $8M | $2M | $17M | $9M | $8M | $22M | $5M | $9M | |
| Interest Expense | · | · | $25M | $18M | $17M | $17M | $15M | $16M | $5M | $3M | $62.0K | $175.0K | |
| Interest Income | $763.0K | $1M | $1M | $147.0K | $79.0K | $217.0K | $738.0K | $226.0K | $212.0K | $72.0K | $45.0K | $50.0K | |
| Other Non-op | $10M | $-10M | $-3M | $-3M | $-6M | $-3M | $-1M | $-141.0K | $260.0K | $-437.0K | $-484.0K | $-540.0K | |
| Pretax Income | $15M | $-8M | $-22M | $-15M | $-15M | $-17M | $2M | $-6M | $4M | $18M | $6M | $9M | |
| Income Tax | $5M | $6M | $9M | $4M | $7.0K | $-492.0K | $-76.0K | $-4M | $-143.0K | $8M | $2M | $1M | |
| Net Income | $10M | $-13M | $-31M | $-19M | $-15M | $-17M | $2M | $-3M | $4M | $11M | $4M | $7M | |
| EPS (Basic) | $0.22 | $-0.32 | $-0.75 | $-0.48 | $-0.38 | $-0.44 | $0.05 | $-0.08 | $0.11 | $0.33 | $0.14 | $0.26 | |
| EPS (Diluted) | $0.21 | $-0.32 | $-0.75 | $-0.48 | $-0.38 | $-0.44 | $0.05 | $-0.08 | $0.11 | $0.32 | $0.14 | $0.25 | |
| Shares (Basic) | 45,335,000 | 41,676,000 | 40,743,000 | 40,032,000 | 38,983,000 | 37,861,000 | 37,118,000 | 36,412,000 | 33,008,000 | 31,855,000 | 27,744,000 | 27,379,000 | |
| Shares (Diluted) | 47,162,000 | 41,676,000 | 40,743,000 | 40,032,000 | 38,983,000 | 37,861,000 | 37,860,000 | 36,412,000 | 34,163,000 | 32,822,000 | 28,542,000 | 28,313,000 | |
| EBITDA | $56M | $63M | $29M | $29M | $32M | $23M | $35M | $27M | $18M | $30M | · | $15M |
Balance general 28
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $65M | $53M | $59M | $39M | $55M | $61M | $34M | $41M | $40M | $57M | $38M | $33M | |
| Receivables | $90M | $79M | $72M | $62M | $53M | $46M | $53M | $47M | $48M | $28M | $23M | $21M | |
| Inventory | $92M | $80M | $82M | $74M | $77M | $73M | $53M | $45M | $47M | $26M | $15M | $13M | |
| Prepaid Expense | $43M | $19M | $16M | $18M | $15M | $14M | $12M | $7M | $5M | $3M | $5M | $5M | |
| Current Assets | $358M | $290M | $281M | $247M | $248M | $235M | $187M | $179M | $179M | $147M | $110M | $106M | |
| PP&E (Net) | $65M | $36M | $38M | $39M | $38M | $33M | $32M | $31M | $34M | $19M | $11M | $12M | |
| PP&E (Gross) | · | · | · | $127M | $120M | $111M | $103M | $96M | $93M | $74M | $64M | $62M | |
| Accum. Depreciation | · | · | · | $88M | $82M | $78M | $71M | $65M | $60M | $55M | $53M | $50M | |
| Goodwill | $254M | $241M | $247M | $244M | $250M | $260M | $187M | $189M | $188M | $78M | $11M | $11M | |
| Intangibles | $124M | $128M | $143M | $151M | $167M | $186M | $115M | $118M | $130M | $1M | $1M | $2M | |
| Other Non-current Assets | $15M | $24M | $9M | $7M | $8M | $15M | $14M | $8M | $7M | $2M | $6M | $5M | |
| Total Assets | $885M | $789M | $792M | $763M | $793M | $789M | $606M | $571M | $590M | $316M | $181M | $176M | |
| Accounts Payable | $16M | $18M | $13M | $12M | $10M | $10M | $10M | $8M | $10M | $6M | $5M | $4M | |
| Accrued Liabilities | $16M | $12M | $10M | $12M | $8M | $7M | $7M | $7M | $12M | $5M | $3M | $3M | |
| Current Liabilities | $102M | $67M | $58M | $50M | $45M | $60M | $45M | $35M | $43M | $30M | $20M | $21M | |
| Capital Leases | $34M | $40M | $44M | $41M | $45M | $14M | $18M | $0 | $7M | $11.0K | · | · | |
| Deferred Tax | $24M | $20M | $22M | $24M | $29M | $35M | $26M | $27M | $30M | $7.0K | · | · | |
| Other Non-current Liabilities | $9M | $8M | $7M | $7M | $6M | $7M | $7M | $7M | $8M | $5M | $3M | $3M | |
| Total Liabilities | $437M | $513M | $511M | $478M | $492M | $461M | $320M | $296M | $313M | $107M | $26M | $27M | |
| Long-term Debt | $215M | $314M | $307M | $308M | $309M | $292M | $216M | $217M | $219M | $72M | · | · | |
| Total Debt | $215M | $314M | $307M | $308M | $309M | $292M | $216M | $217M | $219M | $72M | · | · | |
| Common Stock | $493.0K | $434.0K | $426.0K | $418.0K | $414.0K | $404.0K | $390.0K | $385.0K | $376.0K | $342.0K | $298.0K | $292.0K | |
| Retained Earnings | $-51M | $-61M | $-48M | $-17M | $2M | $20M | $37M | $35M | $38M | $34M | $23M | $23M | |
| Treasury Stock | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $13M | $12M | $11M | $9M | |
| AOCI | $-3M | $-25M | $-12M | $-22M | $-10M | $7M | $-9M | $-6M | $2M | $-429.0K | $-76.0K | $-121.0K | |
| Stockholders' Equity | $448M | $276M | $282M | $284M | $301M | $329M | $286M | $275M | $277M | $209M | $155M | $149M | |
| Liabilities + Equity | $885M | $789M | $792M | $763M | $793M | $789M | $606M | $571M | $590M | $316M | $181M | $176M | |
| Shares Outstanding | 49,330,000 | 43,432,000 | 42,569,000 | 41,830,000 | 41,397,000 | 40,394,000 | 39,018,000 | 38,463,000 | 37,618,000 | 34,230,000 | 29,766,000 | 29,229,000 |
Flujo de Efectivo 19
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $22M | $24M | $23M | $22M | $24M | $21M | $18M | $18M | $10M | $8M | $6M | $6M | |
| Stock-based Comp | $24M | $14M | $14M | $12M | $11M | $7M | $9M | $6M | $7M | $6M | $5M | $3M | |
| Deferred Tax | $37.0K | $-2M | $-1M | $-885.0K | $-6M | $816.0K | $-2M | $-6M | $-1M | $3M | $1M | $173.0K | |
| Amort. of Intangibles | $14M | $16M | $15M | $15M | $17M | $14M | $11M | $11M | $5M | $4M | $2M | $2M | |
| Other Non-cash | $-17M | $-1M | $13M | $-20M | $-17M | $611.0K | $-11M | $-5M | $-8M | $-8M | · | $-9M | |
| Operating Cash Flow | $40M | $22M | $19M | $-5M | $-3M | $12M | $16M | $10M | $11M | $20M | $11M | $8M | |
| CapEx | $39M | $11M | $10M | $11M | $13M | $7M | $8M | $6M | $7M | $6M | $3M | $4M | |
| Investing Cash Flow | $-42M | $-28M | $-502.0K | $-11M | $6M | $-73M | $-24M | $-7M | $-171M | $-79M | $-4M | · | |
| Debt Issued | $0 | $184M | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $-210.0K | $-28M | $-3M | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $13M | $6M | $4M | $3M | $4M | $2M | $5M | $4M | $3M | $2M | $2M | $3M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | $6M | |
| Net Stock Activity | $13M | $6M | $4M | $3M | $4M | $2M | $5M | $4M | $3M | $2M | · | $-3M | |
| Dividends Paid | · | · | · | · | · | · | · | · | · | · | $3M | $3M | |
| Financing Cash Flow | $11M | $2M | $865.0K | $-2M | $-12M | $94M | $-1M | $-3M | $143M | $73M | $-3M | · | |
| Net Change in Cash | $11M | $-5M | $20M | $-16M | $-7M | $28M | $-8M | $1M | $-17M | $14M | $4M | $-4M | |
| Taxes Paid | $3M | · | · | · | · | · | · | · | · | · | $145.0K | $3M | |
| Free Cash Flow | $839.0K | $11M | $11M | $-14M | $-16M | $5M | $8M | $4M | $4M | $14M | · | $4M | |
| Levered FCF | · | · | $-25M | $-38M | $-33M | $-11M | $-8M | $-3M | $-925.8K | $12M | · | · |
Rentabilidad 8
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 64.4% | 64.0% | 64.7% | 64.5% | 66.1% | 66.3% | 66.3% | 65.8% | 67.8% | 65.9% | · | 63.1% | |
| Operating Margin | 7.6% | 10.0% | 1.6% | 2.0% | 2.7% | 0.96% | 6.2% | 3.5% | 4.2% | 12.1% | · | 6.1% | |
| Net Margin | 2.2% | -3.4% | -8.7% | -6.1% | -5.0% | -6.6% | 0.62% | -1.1% | 1.9% | 6.0% | · | 5.1% | |
| Pretax Margin | 3.4% | -1.9% | -6.1% | -4.8% | -5.0% | -6.8% | 0.60% | -2.4% | 1.9% | 10.2% | · | 6.0% | |
| EBITDA Margin | 12.7% | 16.2% | 8.1% | 9.1% | 10.7% | 9.1% | 12.8% | 10.4% | 9.3% | 16.7% | · | 10.3% | |
| ROA | 1.2% | -1.7% | -4.0% | -2.5% | -1.9% | -2.4% | 0.29% | -0.49% | 0.82% | 4.3% | · | 4.2% | |
| ROE | 2.2% | -4.6% | -11.1% | -7.1% | -4.9% | -5.1% | 0.61% | -1.0% | 1.5% | 5.9% | · | 5.0% | |
| ROIC | 3.4% | 11.7% | 1.4% | 1.3% | 1.3% | 0.38% | 3.6% | 0.84% | 1.7% | 4.5% | · | 5.0% |
Liquidez y Solvencia 5
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | 4.3 | 4.9 | 5.0 | 5.5 | 3.9 | 4.1 | 5.2 | 4.2 | 4.9 | · | 5.1 | |
| Quick Ratio | 1.5 | 2.0 | 2.3 | 2.0 | 2.4 | 1.8 | 1.9 | 2.6 | 2.0 | 2.8 | · | 2.6 | |
| Debt / Equity | 0.5 | 1.1 | 1.1 | 1.1 | 1.0 | 0.9 | 0.8 | 0.8 | 0.8 | 0.3 | · | · | |
| LT Debt / Equity | 0.5 | 1.1 | 1.1 | 1.1 | 1.0 | 0.9 | 0.8 | 0.8 | 0.8 | 0.3 | · | · | |
| Interest Coverage | · | · | 0.2 | 0.3 | 0.5 | 0.1 | 1.1 | 0.6 | 1.6 | 7.3 | · | · |
Eficiencia 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.5 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.4 | 0.7 | · | 0.8 | |
| Inventory Turnover | 1.8 | 1.7 | 1.6 | 1.5 | 1.4 | 1.4 | 1.9 | 1.9 | 1.7 | 3.0 | · | 4.7 | |
| Receivables Turnover | 5.2 | 5.1 | 5.3 | 5.5 | 6.0 | 5.1 | 5.5 | 5.6 | 5.0 | 7.0 | · | 7.4 |
Tasas de Crecimiento 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 13.6% | 9.8% | 12.8% | 5.0% | 18.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 12.0% | 9.1% | 11.8% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.8% | · | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM) 17
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $441M | $389M | $354M | $314M | $299M | $253M | $276M | $263M | $190M | $180M | $146M | $145M | |
| Net Income TTM | $10M | $-13M | $-31M | $-19M | $-15M | $-17M | $2M | $-3M | $4M | $11M | $4M | $7M | |
| Market Cap | $2.25B | $1.24B | $761M | $507M | $842M | $954M | $1.06B | $1.09B | $720M | $656M | · | $331M | |
| Enterprise Value | $2.40B | $1.50B | $1.01B | $776M | $1.10B | $1.18B | $1.24B | $1.27B | $899M | $670M | · | · | |
| P/E | 217.2 | -89.3 | -23.8 | -25.2 | -53.6 | -53.7 | 541.8 | -354.8 | 174.1 | 59.8 | 77.0 | 45.3 | |
| P/S | 5.1 | 3.2 | 2.2 | 1.6 | 2.8 | 3.8 | 3.8 | 4.2 | 3.8 | 3.6 | · | 2.3 | |
| P/B | 5.0 | 4.5 | 2.7 | 1.8 | 2.8 | 2.9 | 3.7 | 4.0 | 2.6 | 3.1 | · | 2.2 | |
| P / Tangible Book | 31.9 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 56.4 | 55.8 | 40.4 | -98.4 | -325.9 | 77.1 | 66.8 | 110.5 | 66.7 | 33.2 | · | 40.8 | |
| P / FCF | 2681.7 | 112.4 | 66.8 | -35.8 | -53.7 | 189.2 | 136.3 | 266.6 | 172.7 | 48.5 | · | 87.0 | |
| EV / EBITDA | 42.7 | 23.8 | 35.0 | 27.1 | 34.2 | 51.1 | 35.0 | 46.2 | 50.8 | 22.2 | · | · | |
| EV / FCF | 2860.7 | 136.0 | 88.6 | -54.7 | -70.0 | 234.9 | 159.8 | 309.4 | 215.6 | 49.6 | · | · | |
| EV / Revenue | 5.4 | 3.9 | 2.9 | 2.5 | 3.7 | 4.7 | 4.5 | 4.8 | 4.7 | 3.7 | · | · | |
| Dividend Yield | · | · | · | · | · | · | · | · | · | · | · | 0.99% | |
| Earnings Yield | 0.46% | -1.1% | -4.2% | -4.0% | -1.9% | -1.9% | 0.18% | -0.28% | 0.57% | 1.7% | 1.3% | 2.2% | |
| Payout Ratio | · | · | · | · | · | · | · | · | · | · | · | 45.0% | |
| Annual Payout | · | · | · | · | · | · | · | · | · | · | $3M | $3M |
Estado de resultados 18
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $126M | $116M | $116M | $113M | $113M | $99M | $97M | $96M | $98M | $97M | $94M | $88M | $89M | $83M | $79M | $77M | |
| Cost of Revenue | $45M | $41M | $43M | $39M | $40M | $35M | $36M | $35M | $35M | $34M | $33M | $32M | $31M | $30M | $29M | $28M | |
| Gross Profit | $81M | $75M | $73M | $74M | $73M | $64M | $62M | $61M | $63M | $63M | $61M | $56M | $58M | $54M | $51M | $49M | |
| R&D Expense | $9M | $9M | $9M | $8M | $7M | $7M | $7M | $7M | $7M | $7M | $8M | $6M | $7M | $7M | $8M | $12M | |
| SG&A Expense | $80M | $61M | $57M | $57M | $58M | $55M | $51M | $50M | $49M | $31M | $50M | $51M | $57M | $50M | $38M | $41M | |
| Operating Expenses | $89M | $70M | $66M | $65M | $65M | $61M | $59M | $57M | $57M | $38M | $58M | $58M | $65M | $58M | $47M | $53M | |
| Operating Income | $-8M | $6M | $11M | $13M | $8M | $2M | $3M | $4M | $7M | $25M | $3M | $-1M | $8M | $-4M | $4M | $-4M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $8M | · | $7M | $6M | $6M | · | $5M | |
| Interest Income | $367.0K | $205.0K | $311.0K | $240.0K | $68.0K | $144.0K | $374.0K | $366.0K | $353.0K | $374.0K | $398.0K | $339.0K | $265.0K | $75.0K | $61.0K | $40.0K | |
| Other Non-op | $4M | $-286.0K | $1M | $399.0K | $5M | $3M | $-10M | $2M | $-983.0K | $-1M | $2M | $-2M | $-4M | $963.0K | $4M | $-4M | |
| Pretax Income | $-12M | $339.0K | $7M | $7M | $3M | $-2M | $-17M | $-1M | $-2M | $13M | $-591.0K | $-9M | $-3M | $-9M | $3M | $-13M | |
| Income Tax | $2M | $-1M | $4M | $554.0K | $2M | $-2M | $-119.0K | $1M | $-306.0K | $5M | $3M | $382.0K | $725.0K | $5M | $1M | $1M | |
| Net Income | $-14M | $1M | $2M | $7M | $1M | $-505.0K | $-16M | $-2M | $-2M | $8M | $-4M | $-10M | $-3M | $-14M | $2M | $-14M | |
| EPS (Basic) | $-0.28 | $0.03 | $0.06 | $0.14 | $0.03 | $-0.01 | $-0.40 | $-0.05 | $-0.05 | $0.18 | $-0.10 | $-0.24 | $-0.08 | $-0.33 | $0.05 | $-0.34 | |
| EPS (Diluted) | $-0.28 | $0.03 | $0.06 | $0.13 | $0.03 | $-0.01 | $-0.40 | $-0.05 | $-0.05 | $0.18 | $-0.10 | $-0.24 | $-0.08 | $-0.33 | $0.05 | $-0.34 | |
| Shares (Basic) | 48,541,000 | 48,074,000 | -88,426,000 | 47,233,000 | 44,296,000 | 42,232,000 | -83,141,000 | 41,844,000 | 41,683,000 | 41,290,000 | -81,325,000 | 40,881,000 | 40,755,000 | 40,432,000 | -79,964,000 | 40,115,000 | |
| Shares (Diluted) | 48,541,000 | 49,731,000 | -89,223,000 | 48,775,000 | 45,378,000 | 42,232,000 | -89,737,000 | 41,844,000 | 41,683,000 | 47,886,000 | -81,325,000 | 40,881,000 | 40,755,000 | 40,432,000 | -79,964,000 | 40,115,000 | |
| EBITDA | $-8M | $12M | · | $13M | $8M | $8M | · | $4M | $7M | $31M | · | $-1M | $8M | $2M | · | $-4M |
Balance general 26
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $77M | $56M | $65M | $73M | $53M | $38M | $53M | $56M | $55M | $51M | · | $53M | $49M | $31M | · | $38M | |
| Receivables | $98M | $92M | $90M | $88M | $91M | $88M | $79M | $76M | $74M | $74M | · | $64M | $65M | $63M | · | $57M | |
| Inventory | $103M | $98M | $92M | $91M | $87M | $82M | $80M | $84M | $81M | $82M | · | $79M | $78M | $76M | · | $73M | |
| Prepaid Expense | $27M | $45M | $43M | $22M | $25M | $20M | $19M | $19M | $20M | $17M | · | $17M | $19M | $20M | · | $17M | |
| Current Assets | $371M | $358M | $358M | $337M | $319M | $287M | $290M | $288M | $285M | $277M | · | $267M | $264M | $241M | · | $238M | |
| PP&E (Net) | $74M | $68M | $65M | $41M | $40M | $38M | $36M | $38M | $37M | $38M | · | $37M | $38M | $39M | · | $36M | |
| Goodwill | $350M | $252M | $254M | $254M | $254M | $245M | $241M | $249M | $244M | $245M | $247M | $243M | $246M | $246M | $244M | $235M | |
| Intangibles | $149M | $120M | $124M | $126M | $129M | $128M | $128M | $135M | $135M | $138M | · | $143M | $147M | $150M | · | $148M | |
| Other Non-current Assets | $15M | $16M | $15M | $29M | $27M | $25M | $24M | $21M | $14M | $13M | · | $8M | $8M | $8M | · | $7M | |
| Total Assets | $1.07B | $883M | $885M | $858M | $838M | $791M | $789M | $803M | $790M | $784M | · | $775M | $778M | $757M | · | $743M | |
| Accounts Payable | $21M | $18M | $16M | $16M | $19M | $12M | $18M | $11M | $12M | $10M | · | $11M | $10M | $9M | · | $11M | |
| Accrued Liabilities | $16M | $17M | $16M | $12M | $11M | $12M | $12M | $16M | $16M | $16M | · | $10M | $10M | $10M | · | $10M | |
| Current Liabilities | $107M | $93M | $102M | $86M | $67M | $52M | $67M | $153M | $51M | $46M | · | $55M | $56M | $44M | · | $46M | |
| Capital Leases | $36M | $34M | $34M | $38M | $39M | $39M | $40M | $41M | $42M | $43M | · | $43M | $40M | $41M | · | $41M | |
| Deferred Tax | $26M | $28M | $24M | $22M | $23M | $22M | $20M | $19M | $22M | $22M | · | $20M | $19M | $24M | · | $34M | |
| Other Non-current Liabilities | $9M | $9M | $9M | $9M | $9M | $8M | $8M | $8M | $8M | $8M | · | $8M | $7M | $7M | · | $7M | |
| Total Liabilities | $626M | $433M | $437M | $419M | $418M | $497M | $513M | $498M | $494M | $489M | · | $503M | $495M | $477M | · | $488M | |
| Long-term Debt | $363M | $215M | $215M | $215M | $216M | $315M | $314M | $314M | $314M | $313M | · | $307M | $308M | $308M | · | $308M | |
| Total Debt | $363M | $215M | · | $215M | $216M | $315M | · | $314M | $314M | $313M | · | $307M | $308M | $308M | · | $308M | |
| Common Stock | $502.0K | $500.0K | $493.0K | $488.0K | $486.0K | $442.0K | $434.0K | $434.0K | $433.0K | $432.0K | · | $425.0K | $424.0K | $424.0K | · | $418.0K | |
| Retained Earnings | $-64M | $-50M | $-51M | $-54M | $-60M | $-62M | $-61M | $-45M | $-42M | $-40M | · | $-44M | $-34M | $-31M | · | $-19M | |
| Treasury Stock | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | · | $15M | $15M | $15M | · | $15M | |
| AOCI | $-12M | $-12M | $-3M | $-2M | $-3M | $-19M | $-25M | $-10M | $-16M | $-14M | · | $-21M | $-16M | $-18M | · | $-45M | |
| Stockholders' Equity | $446M | $450M | $448M | $439M | $420M | $294M | $276M | $305M | $295M | $295M | $282M | $272M | $283M | $280M | $284M | $255M | |
| Liabilities + Equity | $1.07B | $883M | $885M | $858M | $838M | $791M | $789M | $803M | $790M | $784M | · | $775M | $778M | $757M | · | $743M | |
| Shares Outstanding | 50,179,000 | 49,983,000 | 49,330,000 | 48,862,000 | 48,592,000 | 44,190,000 | 43,432,000 | 43,392,000 | · | · | 42,569,000 | 42,537,000 | 42,443,000 | 42,366,000 | 41,830,000 | 41,816,000 |
Flujo de Efectivo 16
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $7M | $6M | $6M | $6M | $6M | $5M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $5M | $6M | |
| Stock-based Comp | $8M | $8M | $4M | $6M | $6M | $8M | $3M | $4M | $4M | $3M | $4M | $3M | $4M | $3M | $3M | $3M | |
| Deferred Tax | · | · | · | · | · | · | $3M | · | · | · | $6M | · | · | · | · | · | |
| Amort. of Intangibles | $4M | $4M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Other Non-cash | · | $-15M | · | · | · | $-30M | · | · | · | $-22M | · | · | · | $-2M | · | · | |
| Operating Cash Flow | $-1M | $1M | $20M | $22M | $15M | $-17M | $10M | $11M | $6M | $-5M | $11M | $7M | $7M | $-6M | $-217.0K | $4M | |
| CapEx | $11M | $8M | $28M | $5M | $3M | $4M | $1M | $4M | $3M | $4M | $3M | $3M | $3M | $3M | $4M | $3M | |
| Investing Cash Flow | $-129M | $-11M | $-31M | $-5M | $-3M | $-4M | $-11M | $-11M | $-3M | $-4M | $-3M | $-2M | $7M | $-3M | $-3M | $-3M | |
| Debt Issued | · | · | $0 | $0 | $0 | $0 | $-6M | $160M | $160M | $190M | $0 | $0 | $0 | $0 | · | · | |
| Net Debt Issued | · | $0 | · | · | · | $-66.0K | · | · | · | $-182M | · | · | · | · | · | · | |
| Stock Issued | $1M | $1M | $3M | $5M | $278.0K | $4M | $443.0K | $2M | $59.0K | $4M | $488.0K | $886.0K | $0 | $3M | $24.0K | $1M | |
| Net Stock Activity | · | $1M | · | · | · | $4M | · | · | · | $4M | · | · | · | $3M | · | · | |
| Financing Cash Flow | $152M | $463.0K | $2M | $2M | $3M | $4M | $174.0K | $1M | $-181.0K | $737.0K | $-2M | $-909.0K | $2M | $1M | $-859.0K | $252.0K | |
| Net Change in Cash | $22M | $-9M | $-9M | $20M | $16M | $-16M | $-3M | $1M | $4M | $-8M | $5M | $5M | $18M | $-9M | $2M | $-3M | |
| Free Cash Flow | · | $-7M | · | · | · | $-21M | · | · | · | $-9M | · | · | · | $-8M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-14M | · | · | · | $-18M | · | · |
Rentabilidad 8
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 64.0% | 64.8% | · | 65.6% | 64.7% | 64.2% | · | 63.7% | 64.6% | 64.6% | · | 64.0% | 65.1% | 64.5% | · | 63.4% | |
| Operating Margin | -6.7% | 5.0% | · | 11.1% | 7.4% | 2.2% | · | 4.6% | 6.6% | 26.0% | · | -1.4% | 8.6% | -4.6% | · | -5.3% | |
| Net Margin | -10.7% | 1.2% | · | 5.7% | 1.2% | -0.51% | · | -2.4% | -2.2% | 7.7% | · | -11.2% | -3.8% | -16.3% | · | -17.8% | |
| Pretax Margin | -9.3% | 0.29% | · | 6.2% | 3.1% | -2.3% | · | -1.3% | -2.5% | 13.1% | · | -10.7% | -3.0% | -10.7% | · | -16.3% | |
| EBITDA Margin | -6.7% | 10.4% | · | 11.1% | 7.4% | 7.7% | · | 4.6% | 6.6% | 32.0% | · | -1.4% | 8.6% | 2.2% | · | -5.3% | |
| ROA | -1.4% | 0.17% | · | 0.78% | 0.17% | -0.06% | · | -0.29% | -0.27% | 0.98% | · | -1.3% | -0.44% | -1.8% | · | -1.8% | |
| ROE | -3.1% | 0.38% | · | 1.8% | 0.38% | -0.17% | · | -0.79% | -0.73% | 2.6% | · | -3.7% | -1.2% | -4.7% | · | -4.8% | |
| ROIC | -1.2% | 3.6% | · | 1.8% | 0.51% | 0.08% | · | 1.3% | 0.93% | 2.5% | · | -0.22% | 1.7% | -1.0% | · | -0.80% |
Liquidez y Solvencia 5
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | 3.9 | · | 3.9 | 4.8 | 5.5 | · | 1.9 | 5.6 | 6.0 | · | 4.9 | 4.7 | 5.5 | · | 5.2 | |
| Quick Ratio | 1.6 | 1.6 | · | 1.9 | 2.2 | 2.4 | · | 0.9 | 2.5 | 2.7 | · | 2.1 | 2.0 | 2.1 | · | 2.1 | |
| Debt / Equity | 0.8 | 0.5 | · | 0.5 | 0.5 | 1.1 | · | 1.0 | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.1 | · | 1.2 | |
| LT Debt / Equity | 0.8 | 0.5 | · | 0.5 | 0.5 | 1.1 | · | 0.7 | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.1 | · | 1.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 3.2 | · | -0.2 | 1.2 | -0.6 | · | -0.9 |
Eficiencia 3
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.5 | 0.5 | · | 0.4 | 0.5 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| Receivables Turnover | 1.3 | 1.3 | · | 1.4 | 1.4 | 1.2 | · | 1.4 | 1.4 | 1.4 | · | 1.4 | 1.5 | 1.4 | · | 1.4 |
Valoración (TTM) 14
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $468M | $442M | · | $421M | $406M | $390M | · | $379M | $373M | $358M | · | $337M | $330M | $318M | · | $307M | |
| Net Income TTM | $-4M | $9M | · | $5M | $-4M | $3M | · | $-7M | $-8M | $-19M | · | $-40M | $-35M | $-35M | · | $-11M | |
| Market Cap | $1.13B | $1.83B | · | $2.07B | $1.51B | $1.09B | · | $1.16B | · | · | · | $645M | $730M | $555M | · | $579M | |
| Enterprise Value | $1.41B | $1.99B | · | $2.21B | $1.67B | $1.36B | · | $1.41B | · | · | · | $899M | $988M | $832M | · | $849M | |
| P/E | -249.7 | 203.4 | · | 423.4 | -388.8 | 351.1 | · | -166.4 | -135.0 | -45.0 | · | -15.3 | -20.0 | -15.2 | · | -51.3 | |
| P/S | 2.4 | 4.1 | · | 4.9 | 3.7 | 2.8 | · | 3.0 | · | · | · | 1.9 | 2.2 | 1.7 | · | 1.9 | |
| P/B | 2.5 | 4.1 | · | 4.7 | 3.6 | 3.7 | · | 3.8 | · | · | · | 2.4 | 2.6 | 2.0 | · | 2.3 | |
| P / Tangible Book | · | 23.2 | · | 35.5 | 41.0 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | 1586.1 | · | · | · | -64.1 | · | · | · | · | · | · | · | -90.2 | · | · | |
| P / FCF | · | -267.2 | · | · | · | -52.8 | · | · | · | · | · | · | · | -66.1 | · | · | |
| EV / EBITDA | -169.0 | 164.1 | · | 176.3 | 199.6 | 179.6 | · | 322.1 | · | · | · | -722.5 | 128.8 | 444.3 | · | -206.9 | |
| EV / FCF | · | -290.5 | · | · | · | -66.2 | · | · | · | · | · | · | · | -99.2 | · | · | |
| EV / Revenue | 3.0 | 4.5 | · | 5.2 | 4.1 | 3.5 | · | 3.7 | · | · | · | 2.7 | 3.0 | 2.6 | · | 2.8 | |
| Earnings Yield | -0.40% | 0.49% | · | 0.24% | -0.26% | 0.28% | · | -0.60% | -0.74% | -2.2% | · | -6.5% | -5.0% | -6.6% | · | -1.9% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ingresos | $441M | $389M | $354M | $314M | $299M |
| Margen Bruto % | 64.4% | 64.0% | 64.7% | 64.5% | 66.1% |
| Margen Operativo % | 7.6% | 10.0% | 1.6% | 2.0% | 2.7% |
| Beneficio neto | $10M | $-13M | $-31M | $-19M | $-15M |
| EPS Diluido | $0.21 | $-0.32 | $-0.75 | $-0.48 | $-0.38 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Deuda / Patrimonio | 0.5 | 1.1 | 1.1 | 1.1 | 1.0 |
| Ratio corriente | 3.5 | 4.3 | 4.9 | 5.0 | 5.5 |
| Ratio Rápido | 1.5 | 2.0 | 2.3 | 2.0 | 2.4 |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $839.0K | $11M | $11M | $-14M | $-16M |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 217 declarantes · $728.9M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 42 (+7 vs trimestre anterior) | 64 (+28 vs trimestre anterior) | 80 (-7 vs trimestre anterior) | 47 (-16 vs trimestre anterior) | +5.4M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $71 566 000 | 3 184 974 | 9,82% | Acciones |
| Juniper Investment Company, LLC | $45 386 816 | 2 019 885 | 6,23% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $45 043 789 | 2 004 619 | 6,18% | Acciones |
| FMR LLC | $41 871 497 | 1 863 440 | 5,74% | Acciones |
| STATE STREET CORP | $41 750 406 | 1 858 051 | 5,73% | Acciones |
| Ophir Asset Management Pty Ltd | $40 446 180 | 1 800 008 | 5,55% | Acciones |
| PERCEPTIVE ADVISORS LLC | $39 036 906 | 1 737 290 | 5,36% | Acciones |
| Conestoga Capital Advisors, LLC | $36 484 539 | 1 623 700 | 5,01% | Acciones |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $23 011 325 | 1 024 091 | 3,16% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $22 205 281 | 988 219 | 3,05% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $21 427 261 | 953 365 | 2,94% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $20 062 856 | 892 873 | 2,75% | Acciones |
| CITADEL ADVISORS LLC | $17 701 821 | 787 798 | 2,43% | Acciones |
| YARGER WEALTH STRATEGIES, LLC | $15 278 432 | 634 223 | 2,10% | Acciones |
| ROYCE & ASSOCIATES LP | $14 364 667 | 639 282 | 1,97% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $11 702 264 | 520 795 | 1,61% | Acciones |
| Qube Research & Technologies Ltd | $10 704 820 | 476 405 | 1,47% | Acciones |
| FRED ALGER MANAGEMENT, LLC | $10 406 104 | 463 111 | 1,43% | Acciones |
| TWO SIGMA ADVISERS, LP | $9 974 907 | 218 700 | 1,37% | Acciones |
| D. E. Shaw & Co., Inc. | $9 846 714 | 438 216 | 1,35% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $9 183 579 | 408 704 | 1,26% | Acciones |
| Toroso Investments, LLC | $9 018 146 | 197 723 | 1,24% | Acciones |
| Soleus Capital Management, L.P. | $8 718 360 | 388 000 | 1,20% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $8 702 159 | 387 279 | 1,19% | Acciones |
| Balyasny Asset Management L.P. | $8 584 686 | 382 051 | 1,18% | Acciones |
| GOLDMAN SACHS GROUP INC | $7 733 095 | 344 152 | 1,06% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $6 978 103 | 310 552 | 0,96% | Acciones |
| KENNEDY CAPITAL MANAGEMENT LLC | $6 611 371 | 294 231 | 0,91% | Acciones |
| UBS Group AG | $6 026 544 | 268 204 | 0,83% | Acciones |
| WASATCH ADVISORS LP | $5 726 929 | 156 388 | 0,79% | Acciones |
| BRIDGER MANAGEMENT, LLC | $4 855 373 | 132 588 | 0,67% | Acciones |
| Quantinno Capital Management LP | $4 497 191 | 200 142 | 0,62% | Acciones |
| AMERIPRISE FINANCIAL INC | $4 347 068 | 193 461 | 0,60% | Acciones |
| FIFTH THIRD BANCORP | $4 170 912 | 185 621 | 0,57% | Acciones |
| ORBIMED ADVISORS LLC | $3 932 250 | 175 000 | 0,54% | Acciones |
| Corient Private Wealth LP | $3 578 618 | 159 262 | 0,49% | Acciones |
| Public Sector Pension Investment Board | $3 298 304 | 146 787 | 0,45% | Acciones |
| Parkman Healthcare Partners LLC | $3 121 982 | 138 940 | 0,43% | Acciones |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $2 879 149 | 128 133 | 0,40% | Acciones |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $2 857 263 | 127 159 | 0,39% | Acciones |
| Summit Creek Advisors LLC | $2 704 354 | 120 354 | 0,37% | Acciones |
| CONNORS INVESTOR SERVICES INC | $2 700 445 | 120 180 | 0,37% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $2 693 816 | 119 885 | 0,37% | Acciones |
| Bank of New York Mellon Corp | $2 522 415 | 112 257 | 0,35% | Acciones |
| RHUMBLINE ADVISERS | $2 373 280 | 105 621 | 0,33% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2 303 872 | 102 531 | 0,32% | Acciones |
| XTX Topco Ltd | $2 173 905 | 96 747 | 0,30% | Acciones |
| Swiss National Bank | $1 914 444 | 85 200 | 0,26% | Acciones |
| BANK OF AMERICA CORP /DE/ | $1 912 535 | 85 115 | 0,26% | Acciones |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1 875 420 | 51 213 | 0,26% | Acciones |
| LAZARD ASSET MANAGEMENT LLC | $1 875 301 | 83 458 | 0,26% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $1 524 073 | 67 827 | 0,21% | Acciones |
| ALLIANCEBERNSTEIN L.P. | $1 522 477 | 41 575 | 0,21% | Acciones |
| Legal & General Group Plc | $1 468 954 | 65 374 | 0,20% | Acciones |
| CITIGROUP INC | $1 425 856 | 63 456 | 0,20% | Acciones |
| Squarepoint Ops LLC | $1 424 238 | 63 384 | 0,20% | Acciones |
| Russell Investments Group, Ltd. | $1 303 125 | 57 994 | 0,18% | Acciones |
| VICTORY CAPITAL MANAGEMENT INC | $1 193 157 | 53 100 | 0,16% | Acciones |
| ENVESTNET ASSET MANAGEMENT INC | $1 117 972 | 49 754 | 0,15% | Acciones |
| Sterling Capital Management LLC | $1 098 918 | 48 906 | 0,15% | Acciones |
| Sio Capital Management, LLC | $1 089 368 | 48 481 | 0,15% | Acciones |
| BOOTHBAY FUND MANAGEMENT, LLC | $1 010 521 | 44 972 | 0,14% | Acciones |
| PRUDENTIAL FINANCIAL INC | $995 219 | 44 291 | 0,14% | Acciones |
| WELLS FARGO & COMPANY/MN | $937 314 | 41 714 | 0,13% | Acciones |
| VANGUARD GROUP INC | $898 699 | 19 704 | 0,12% | Acciones |
| FIRST TRUST ADVISORS LP | $857 657 | 38 169 | 0,12% | Acciones |
| BlackRock, Inc. | $789 461 | 35 134 | 0,11% | Acciones |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $738 274 | 32 856 | 0,10% | Acciones |
| Verition Fund Management LLC | $729 399 | 32 461 | 0,10% | Acciones |
| Aquatic Capital Management LLC | $712 771 | 31 721 | 0,10% | Acciones |
| Jain Global LLC | $680 908 | 30 303 | 0,09% | Acciones |
| JONES FINANCIAL COMPANIES LLLP | $662 072 | 28 042 | 0,09% | Acciones |
| Brevan Howard Capital Management LP | $652 461 | 29 037 | 0,09% | Acciones |
| VANGUARD ASSET MANAGEMENT, Ltd | $634 193 | 28 224 | 0,09% | Acciones |
| JANUS HENDERSON GROUP PLC | $623 335 | 17 038 | 0,09% | Acciones |
| MetLife Investment Management, LLC | $601 050 | 26 749 | 0,08% | Acciones |
| Y-Intercept (Hong Kong) Ltd | $600 735 | 26 735 | 0,08% | Acciones |
| Mariner, LLC | $570 520 | 25 390 | 0,08% | Acciones |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | $561 750 | 25 000 | 0,08% | Acciones |
| Illinois Municipal Retirement Fund | $545 010 | 24 255 | 0,07% | Acciones |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $516 855 | 23 002 | 0,07% | Acciones |
| Walleye Capital LLC | $490 408 | 21 825 | 0,07% | Acciones |
| Penn Capital Management Company, LLC | $489 689 | 21 793 | 0,07% | Acciones |
| ALLSTATE CORP | $483 240 | 21 506 | 0,07% | Acciones |
| EXCHANGE TRADED CONCEPTS, LLC | $476 948 | 21 226 | 0,07% | Acciones |
| MORGAN STANLEY | $476 588 | 21 210 | 0,07% | Acciones |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $473 241 | 21 061 | 0,06% | Acciones |
| Louisiana State Employees Retirement System | $420 189 | 18 700 | 0,06% | Acciones |
| Invesco Ltd. | $409 628 | 18 230 | 0,06% | Acciones |
| DARK FOREST CAPITAL MANAGEMENT LP | $402 123 | 17 896 | 0,06% | Acciones |
| Vanguard Global Advisers, LLC | $371 384 | 16 528 | 0,05% | Acciones |
| Freestone Grove Partners LP | $328 219 | 14 607 | 0,05% | Acciones |
| NEW YORK STATE COMMON RETIREMENT FUND | $324 287 | 14 432 | 0,04% | Acciones |
| JOHNSON INVESTMENT COUNSEL INC | $307 008 | 13 663 | 0,04% | Acciones |
| Police & Firemen's Retirement System of New Jersey | $303 053 | 13 487 | 0,04% | Acciones |
| DIKER MANAGEMENT LLC | $303 000 | 13 500 | 0,04% | Acciones |
| OPPENHEIMER ASSET MANAGEMENT INC. | $284 672 | 12 669 | 0,04% | Acciones |
| GUGGENHEIM CAPITAL LLC | $283 302 | 12 608 | 0,04% | Acciones |
| ELEVATION POINT WEALTH PARTNERS, LLC | $263 303 | 11 718 | 0,04% | Acciones |
| Vestmark Advisory Solutions, Inc. | $263 303 | 11 718 | 0,04% | Acciones |
Informantes de la empresa 49 insiders · 27 directivos · 15 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| James P Mackin | President & CEO | 6 de marzo de 2025 M | 865 283 | 0 | 0 | $0 |
| David Ashley Lee | Executive VP, COO & CFO | 2 de marzo de 2023 S | 347 217 | 0 | 0 | $0 |
| Marshall S. Stanton | SVP, Clinical & MD Affair | 17 de junio de 2025 S | 64 200 | 0 | 0 | $0 |
| John E Davis | Chief Commercial Officer | 11 de marzo de 2025 M | 208 778 | 0 | 0 | $0 |
| Amy Horton | VP, Chief Accounting Officer | 6 de marzo de 2025 S | 146 651 | 0 | 0 | $0 |
| Matthew A Getz | VP, Human Resources | 16 de agosto de 2024 S | 34 116 | 0 | 0 | $0 |
| Florian Tyrs | VP, Global Operations | 27 de febrero de 2024 S | 21 558 | 0 | 0 | $0 |
| Rochelle L. Maney | VP, Quality | 26 de febrero de 2024 S | 44 518 | 0 | 0 | $0 |
| Robert C Thomson | VP Research & Development | 23 de febrero de 2024 A | 13 291 | 0 | 0 | $0 |
| Dennis B Maier | SVP, Operations | 6 de junio de 2023 S | 34 724 | 0 | 0 | $0 |
| Franz Peter Barthold | VP, Research & Development | 8 de noviembre de 2022 A | 32 516 | 0 | 0 | $0 |
| Scott B Capps | VP, Clinical Research | 12 de marzo de 2021 F | 153 203 | 0 | 0 | $0 |
| James M Mcdermid | SVP, CHRO | 14 de marzo de 2019 F | 30 806 | 0 | 0 | $0 |
| Sherry M Saurini | VP, Quality | 14 de marzo de 2019 F | 25 084 | 0 | 0 | $0 |
| William Robert Matthews | Senior VP, Operations, Quality | 5 de marzo de 2018 F | 39 883 | 0 | 0 | $0 |
| David C Gale | VP, Research & Development | 16 de noviembre de 2017 M | 77 135 | 0 | 0 | $0 |
| Steven G Anderson | Former Executive Chairman | 9 de abril de 2015 F | 1 271 846 | 0 | 0 | $0 |
| Bruce G. Anderson | VP, US Sales &Global Marketing | 7 de marzo de 2015 F | 42 106 | 0 | 0 | $0 |
| FRONK DAVID | VP, Regulatory Affairs | 7 de marzo de 2015 F | 110 559 | 0 | 0 | $0 |
| David P. Lang | VP, Int'l Sales & Marketing | 26 de febrero de 2015 A | 73 441 | 0 | 0 | $0 |
| Jeffrey W Burris | Vice President & Gen. Counsel | 15 de agosto de 2014 M | 95 221 | 0 | 0 | $0 |
| Gerald B Seery | Sr. VP, Sales and Marketing | 30 de noviembre de 2012 S | 71 999 | 0 | 0 | $0 |
| Albert E Heacox | Sr. VP Research and Devl | 31 de diciembre de 2011 F | 110 144 | 0 | 0 | $0 |
| Philip A Theodore | VP, General Counsel | 4 de septiembre de 2007 A | 23 100 | 0 | 0 | $0 |
| Sidney B Ashmore | Vice President of Marketing | 18 de enero de 2006 M | 42 728 | 0 | 0 | $0 |
| Kirby S Black | Sr. Vice President, R&D | 21 de septiembre de 2004 M | 55 131 | 0 | 0 | $0 |
| Vander James C Wyk | VP - Product Integrity | 14 de septiembre de 2004 M | 36 165 | 0 | 0 | $0 |
| Anthony B. Semedo | Consejero | 2 de junio de 2026 J | 6 325 | 0 | 0 | $0 |
| Elizabeth A Hoff | Consejero | 22 de mayo de 2025 A | 31 389 | 0 | 0 | $0 |
| Marna P Borgstrom | Consejero | 22 de mayo de 2025 A | 49 088 | 0 | 0 | $0 |
| Jon W Salveson | Consejero | 22 de mayo de 2025 A | 129 840 | 0 | 0 | $0 |
| Jeffrey H Burbank | Consejero | 22 de mayo de 2025 A | 53 796 | 0 | 0 | $0 |
| Daniel J Bevevino | Consejero | 22 de mayo de 2025 A | 150 061 | 0 | 0 | $0 |
| Bullock James | Consejero | 22 de mayo de 2025 A | 68 647 | 0 | 0 | $0 |
| Thomas F Ackerman | Consejero | 22 de mayo de 2025 A | 149 896 | 0 | 0 | $0 |
| Harvey Morgan | Consejero | 30 de agosto de 2021 G | 46 342 | 0 | 0 | $0 |
| Ronald D Mccall | Consejero | 25 de agosto de 2021 S | 121 768 | 0 | 0 | $0 |
| Elkins C Ronald | Consejero | 5 de septiembre de 2018 S | 64 843 | 0 | 0 | $0 |
| James Benson | Consejero | 2 de octubre de 2017 S | 54 086 | 0 | 0 | $0 |
| John M Cook | Consejero | 9 de junio de 2009 M | 85 000 | 0 | 0 | $0 |
| LACY VIRGINIA C | Consejero | 24 de abril de 2007 S | 255 280 | 0 | 0 | $0 |
| VAN DYNE BRUCE J MD | Consejero | 1 de agosto de 2006 A | 12 800 | 0 | 0 | $0 |
| OSS CAPITAL MANAGEMENT | Propietario del 10% | 31 de mayo de 2007 S | 1 918 000 | 0 | 0 | $0 |
| Lance A Berry | — | 14 de agosto de 2026 S | 210 112 | 0 | 1 | $-20 413 |
| Andrew M Green | — | 14 de agosto de 2026 S | 59 643 | 0 | 3 | $-928 248 |
| Jean F Holloway | — | 12 de agosto de 2026 S | 184 118 | 0 | 1 | $-27 835 |
| Michael S Simpson | — | 5 de marzo de 2021 F | 33 698 | 0 | 0 | $0 |
| Thomas J Bogenschuetz | — | 5 de mayo de 2020 A | 23 451 | 0 | 0 | $0 |
| Thomas J Lynch | — | 2 de noviembre de 2004 A | 5 000 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 5 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Juniper Targeted Opportunity Fund, L.P., Juniper HF Investors II, LLC, Juniper Targeted Opportunities, L.P., Juniper Targeted Opportunity Investors, LLC, Juniper Multi-Strategy Fund, L.P., Juniper HF Investors, LLC, Juniper Investment Company, LLC, Alexis P. Michas, John A. Bartholdson ×2 presentaciones | 12 de agosto de 2025 | 4,00% | Enmienda | — | SEC |
| CryoLife, Inc., CL Falcon, Inc. | 11 de mayo de 2011 | — | Presentación inicial | M&A / venta | SEC |
| Michael A. Roth and Brian J. Stark, as joint filers pursuant to Rule 13d-1(k) | 10 de julio de 2007 | — | Presentación inicial | — | SEC |
| Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada | 2 de diciembre de 2005 | — | Presentación inicial | Inversión pasiva | SEC |
| Persona informante no revelada | 18 de marzo de 2005 | — | Presentación inicial | Inversión pasiva | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 53 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| SAWS · ETF Series Solutions | 2,95% | 5 817 NS | 30 de abril de 2026 | N-PORT |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,77% | 26 421 NS | 30 de abril de 2026 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 0,59% | 37 075 SH | 8 de agosto de 2026 | Diario |
| RZG · Invesco Exchange-Traded Fund Trust | 0,44% | 22 725 SH | 8 de agosto de 2026 | Diario |
| SIXL · EXCHANGE TRADED CONCEPTS TRUST | 0,25% | 21 547 NS | 31 de mayo de 2026 | N-PORT |
| ESSC · Strategy Shares | 0,24% | 1 691 NS | 30 de abril de 2026 | N-PORT |
| XSMO · Invesco Exchange-Traded Fund Trust | 0,21% | 246 008 SH | 8 de agosto de 2026 | Diario |
| IHI · iShares Trust | 0,16% | 202 161 SH | 8 de agosto de 2026 | Diario |
| IJT · iShares Trust | 0,13% | 397 869 SH | 8 de agosto de 2026 | Diario |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,11% | 31 285 NS | 30 de abril de 2026 | N-PORT |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,10% | 50 848 SH | 8 de agosto de 2026 | Diario |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,08% | 7 285 SH | 8 de agosto de 2026 | Diario |
| IWO · iShares Trust | 0,08% | 419 028 SH | 8 de agosto de 2026 | Diario |
| XJR · iShares Trust | 0,07% | 5 059 SH | 8 de agosto de 2026 | Diario |
| IJR · iShares Trust | 0,06% | 2 606 468 SH | 8 de agosto de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,06% | 49 054 SH | 8 de agosto de 2026 | Diario |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,05% | 148 966 SH | 8 de agosto de 2026 | Diario |
| RSSL · Global X Funds | 0,05% | 18 968 NS | 30 de abril de 2026 | N-PORT |
| SAA · ProShares Trust | 0,04% | 505 NS | 31 de mayo de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,04% | 158 121 NS | 30 de abril de 2026 | N-PORT |
| IWM · iShares Trust | 0,04% | 1 162 604 SH | 8 de agosto de 2026 | Diario |
| ISCG · iShares Trust | 0,04% | 14 407 SH | 8 de agosto de 2026 | Diario |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,04% | 28 917 SH | 8 de agosto de 2026 | Diario |
| GSSC · Goldman Sachs ETF Trust | 0,03% | 14 525 NS | 31 de mayo de 2026 | N-PORT |
| EBIT · Harbor ETF Trust | 0,03% | 101 NS | 30 de abril de 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 263 046 SH | 8 de agosto de 2026 | Diario |
| SMDX · Tidal Trust III | 0,03% | 999 NS | 30 de abril de 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 27 103 SH | 8 de agosto de 2026 | Diario |
| ITWO · ProShares Trust | 0,02% | 2 057 NS | 31 de mayo de 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 18 392 NS | 30 de abril de 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,02% | 2 917 NS | 30 de abril de 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,02% | 200 917 NS | 31 de mayo de 2026 | N-PORT |
| ISCB · iShares Trust | 0,02% | 2 111 SH | 8 de agosto de 2026 | Diario |
| UWM · ProShares Trust | 0,01% | 1 609 NS | 31 de mayo de 2026 | N-PORT |
| URTY · ProShares Trust | 0,01% | 1 624 NS | 31 de mayo de 2026 | N-PORT |
| JSTC · Tidal Trust I | 0,01% | 1 526 NS | 31 de mayo de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 495 296 SH | 8 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,01% | 127 662 SH | 8 de agosto de 2026 | Diario |
| WSML · iShares Trust | 0,01% | 2 264 SH | 8 de agosto de 2026 | Diario |
| DFAC · Dimensional ETF Trust | 0,01% | 107 410 NS | 30 de abril de 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 1 773 NS | 31 de mayo de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 3 861 NS | 30 de abril de 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 41 NS | 31 de mayo de 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 1 937 NS | 30 de abril de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 8 873 NS | 30 de abril de 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 12 377 NS | 30 de abril de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 61 883 SH | 8 de agosto de 2026 | Diario |
| IWV · iShares Trust | 0,00% | 10 738 SH | 8 de agosto de 2026 | Diario |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 25 635 NS | 31 de mayo de 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 636 NS | 30 de abril de 2026 | N-PORT |